Une candidature complète en une minute
Un CV et une lettre de motivation personnalisés, prêts à envoyer.
CeMM Research Center for Molecular Medicine invites a motivated master’s thesis student to join a project on genetic engineering of senescence and cell death. The position is 12 months and includes hands‑on training in wet-lab biology within a collaborative lab led by Christoph Bock.
The project combines CRISPR, cell death, and aging, with opportunities to contribute to scientific publications and publications.
We are recruiting an ambitious master’s thesis student who wants to pursue groundbreaking biomedical research. This position requires a 12-month commitment. The successful candidate will join the research group led by Christoph Bock at the CeMM Research Center for Molecular Medicine (Austrian Academy of Sciences). The project combines CRISPR, cell death, and aging. It is primarily wet-lab and benefits from a technology development / cell engineering mindset.
We are seeking a motivated master’s thesis student with prior fulltime experience in wet-lab biology (e.g., as part of an experimental Bachelor thesis project and internships). The project is scientifically and technically challenging, and you will receive hands‑on training in a highly supportive and collaborative environment, with the opportunity to contribute to scientific publications. Our research group has a track record of successful mentorship ().
Required experience and skills
Desirable experience and skills
You will be trained in the methods listed below, including biosafety training for work with viral vectors, as part of the research group led by Christoph Bock. Day‑to‑day supervision will be provided by postdoctoral fellow Mihaela Peycheva.
Typical Tasks
We seek to advance biomedicine with technology‑driven research, combining experimental and computational approaches to understand and program epigenetic cell states and to develop cell‑based therapies for cancer and immune diseases.
Main areas of research include:
The Principal Investigator ()
Christoph Bock is a Principal Investigator at the CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences and Professor of [Bio]Medical Informatics at the Medical University of Vienna. He is also the scientific coordinator of the Biomedical Sequencing Facility at CeMM, member of the Human Cell Atlas Organizing Committee, fellow of the European Lab for Learning and Intelligent Systems (ELLIS), and co‑founder of two Vienna‑based start‑up companies (Myllia, Neurolentech). He has received major research awards, including consecutive ERC Starting, Consolidator, and Advanced Grants (2016 to 2032), the Otto Hahn Medal of the Max Planck Society (2009), Overton Prize of the International Society for Computational Biology (2017), and the Erwin Schrödinger Prize of the Austrian Academy of Sciences (2022), and he has been included in the global list of "Highly Cited Researchers" by Clarivate Analytics (ISI Web of Science) each year since 2019.
CeMM is an international research institute of the Austrian Academy of Sciences and a founding member of EU‑LIFE. The mission of CeMM, the Research Center for Molecular Medicine of the Austrian Academy of Sciences is to achieve maximum scientific innovation in molecular medicine to improve healthcare. At CeMM, an international and creative team of scientists and medical doctors pursues free‑minded basic life science research in a large and vibrant hospital environment of outstanding medical tradition and practice. At CeMM, an international and creative team of scientists and medical doctors pursues free‑minded basic life science research in a large and vibrant hospital environment of outstanding medical tradition and practice. CeMM’s research is based on post‑genomic technologies and focuses on societally important diseases, such as immune disorders and infections, cancer, aging and metabolic disorders. CeMM operates in a unique mode of super‑cooperation, connecting biology with medicine, experiments with computation, discovery with translation, and science with society and the arts. CeMM discovers and develops technologies to explore human biology with the purpose of defeating disease at its roots. Because Science is our Medicine! CeMM trains a modern blend of biomedical scientists and is located at the campus of the General Hospital and the Medical University of Vienna. CeMM is a proud recipient of the HR Excellence in Research Award (HRS4R). This award indicates that CeMM takes care of the well‑being of its employees, that the recruitment process is open, fair, and transparent, and that CeMM offers professional appraisals and career development procedures. More than 150 people from 49 nationalities are working at CeMM. The institute promotes equal opportunity and harbors a mix of different talents, backgrounds, competences, and interests.
Applications will be reviewed on a rolling basis. Any application received by 6 January 2027 will be considered. Anticipated start date: flexible.
City Vienna
Position type Part‑time employee
Start of work 01.03.2027